Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi, French Cancer Center Partner on AI-Focused Research

NEW YORK – Hitachi and Centre Léon Bérard (CLB), a cancer center in Lyon, France, said Thursday that they have partnered on research and development aimed at improving the efficiency and efficacy of cancer diagnosis and treatment.

As part of the agreement, they have jointly established a new research laboratory. The Hitachi Lyon Lab, housed at CLB, will study novel ways to detect cancer by applying artificial intelligence to medical imaging and to predict response to radiation therapy using genomic and transcriptomic data. 

The partners said they would apply CLB's clinical expertise and patient data and Hitachi's know-how in diagnostic imaging and AI to develop diagnostic imaging technologies to detect cancer sites and to help radiologists improve diagnosis from CT and MRI scans. In addition, they plan to identify biomarkers from genomic data to predict response to radiation treatment and prognoses after such treatment.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.